日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Management of a localized prostatic adenocarcinoma despite the very high rate of PSA and the large tumor mass: Does PSA level indicate the stage of prostate cancer?

尽管 PSA 水平很高且肿瘤体积很大，但如何治疗局限性前列腺腺癌：PSA 水平是否能指示前列腺癌的分期？

期刊:Radiology Case Reports
影响因子:
doi:10.1016/j.radcr.2023.07.022
El Farhaoui, Hammou; Jdaini, Ahmed; Elabbassi, Oussama; Bounouar, Oualid; Elmoudane, Anouar; Barki, Ali
肿瘤
前列腺癌
肿瘤免疫
PSA
发表日期：2023
文献求助 收藏

Particularities of urological complications in Crohn's disease: Report of two cases

克罗恩病泌尿系统并发症的特殊性：两例报告

期刊:Annals of Medicine and Surgery
影响因子:1.6
doi:10.1016/j.amsu.2022.103903
Elabbassi, Taoufik; Bachar, Amine; Moufakkir, Aziz; El Berni, Yassine; Yaqine, Karim; Lefriyekh, Mohamed Rachid
克罗恩病
发表日期：2022
文献求助 收藏

Long-term outcome of first 300 implanted Absorb bioresorbable vascular scaffolds in an all-comers Middle East population

在中东所有人群中，首批300例植入Absorb生物可吸收血管支架的长期结果

期刊:Journal of International Medical Research
影响因子:1.5
doi:10.1177/0300060518798994
Al Nooryani, Arif; Elabbassi, Wael N; AlBaba, Bassam; Kerfes, Jalal A; Abudaqa, Loai M; Bhatia, Amit; Abdelrahman, Nagwa A; Boskovic, Nikola; Beleslin, Branko
发表日期：2019
文献求助 收藏

Bioresorbable scaffold technology: The yet unfulfilled promise of becoming the workhorse stent in the cardiac catherization laboratory

生物可吸收支架技术：有望成为心脏导管实验室的主力支架，但其前景尚未完全实现

期刊:Egyptian Heart Journal
影响因子:1.4
doi:10.1016/j.ehj.2018.07.004
Elabbassi, Wael; Chowdhury, Mohammed Andaleeb; Hatala, Robert
发表日期：2018
文献求助 收藏

The impact of severity of initial illness, determined by SOFA score, and presence of anemia on outcomes among patients requiring Extra Corporal Membrane Oxygenation (ECMO) support: A single center experience

初始疾病严重程度（以SOFA评分确定）和贫血的存在对需要体外膜肺氧合（ECMO）支持的患者预后的影响：单中心经验

期刊:Indian Heart Journal
影响因子:1.8
doi:10.1016/j.ihj.2017.05.003
Elabbassi, Wael; Aila, Farah Al; Chowdhury, Mohammed Andaleeb; Najib, Ahmed; Zaid, H; Michelin, M; Nooryani, Arif Al
Adhesion/ECM
贫血
代谢
发表日期：2017
文献求助 收藏